3.70 -0.08 (-2.12%)

New 52W Low today

191.0K XNAS Volume

XNAS 20 Mar, 2025 5:30 PM (EDT)



Insider Trading disclosures for Silence Therapeutics Plc - ADR

The latest disclosure was made by Richard Ian Griffiths in Silence Therapeutics Plc - ADR where a trade of 22,632 American Depositary Shares done was reported to US exchanges on March 5, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Richard Ian Griffiths Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 05 Mar 2025 22,632 9,561,299 - - American Depositary Shares
Craig A. Tooman Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 900,000 900,000 - - Employee Share Option (Right to Buy)
Iain Gladstone Ross Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 90,000 90,000 - - Share Option (Right to Buy)
James Lawrence Ede-Golightly Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 48,000 48,000 - - Share Option (Right to Buy)
Michael Harvey Davidson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 48,000 48,000 - - Share Option (Right to Buy)
Steven Joseph Romano EVP and Chief R&D Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 285,000 285,000 - - Employee Share Option (Right to Buy)
David Jakob Lemus Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 48,000 48,000 - - Share Option (Right to Buy)
Rhonda L. Hellums Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 375,000 375,000 - - Employee Share Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures